Researchers fed mice a Western-style high fat diet for roughly six months and compared them with mice on a low-fat regimen. At the end of the feeding period, the high-fat cohort had gained more weight and, investigators reported, developed a larger population of intestinal stem cells that divided more frequently. These stem cells normally replace worn tissue and repair the gut lining. The study team observed that an expanded, actively dividing stem cell pool could increase opportunities for a cell bearing a cancer-driving mutation to expand into an early tumor.
Miyeko Mana, PhD, the senior author, explained to Medical News Today that the increased stem cell number and division rate were central findings. Short sentences state the consequence: more cell divisions mean more replication events. Longer sentences trace the implication—if mutation-bearing cells arise in that larger, more active pool, the chance that one will clonally expand into a neoplastic lesion rises, the study team noted.
The authors examined how the high-fat feeding altered the stem cells at the level of DNA packaging and accessibility. Data indicated changes in which DNA regions were accessible to the transcriptional machinery; the researchers linked those chromatin accessibility shifts to the observed increases in cell proliferation. When mice were switched from the high-fat diet back to a low-fat diet, stem cell behavior—measured as division frequency and apparent activity—returned toward baseline. Yet some molecular marks did not fully reverse.
After four weeks on the low-fat diet, the investigators reported that approximately 18% of the diet-induced DNA accessibility changes remained. That persistence was not merely a static observation: when the investigators reintroduced the high-fat diet, intestinal stem cells in mice with prior exposure responded more quickly and more strongly than stem cells in mice encountering the diet for the first time. The team also observed that early intestinal tumors grew larger in animals with a history of high-fat feeding than in those exposed de novo, suggesting that the lingering chromatin changes may shape later responses to dietary challenge.
Mana told MNT that “what changed was how the DNA was packaged and which regions were accessible to the machinery that turns genes on. Some of those changes were still present weeks after the mice returned to a low-fat diet, even though stem cell activity had returned to baseline.” She added that past diet effects may only become apparent when the intestine faces a subsequent challenge.
Clinical perspective on translating these rodent results came from Ketan Thanki, MD, a colorectal surgeon who was not involved in the research. He commented that this study provides a clearer cellular-level mechanism linking high fat diets and colon cancer risk. He recommended that patients aiming to reduce long-term risk consider lowering chronic, day-to-day fat exposure in their diets. Thanki specifically mentioned pediatric populations, arguing that reducing early-life high-fat exposure could offer long-term benefit, a point he suggested parents and pediatricians should note.
The article is careful to state the model used: mice. It does not present human clinical or epidemiologic data within this report beyond referencing prior literature that links processed and high-fat foods with increased colorectal cancer risk. The publication venue was Stem Cell Reports, and the work focused on chromatin accessibility and stem cell behavior as proximate mechanisms that could plausibly connect diet to tumor initiation and growth.
The study team said they are interested in whether an analogous process occurs in humans and whether persistent changes in DNA packaging influence human cancer risk. The source did not report human validation, did not provide the precise genomic loci affected, and did not include specific sample sizes or statistical values in the article text. Those omissions mean key translational gaps remain: which chromatin regions matter most, whether similar persistence occurs after shorter or earlier-life exposures, and whether dietary modification after exposure can fully reverse molecular risk signals in people.
These gaps frame the next steps researchers identified: verify whether humans show comparable chromatin persistence after high-fat exposure, map the affected regulatory regions, and determine whether and how dietary or pharmacologic interventions can erase or mitigate those marks. The article stops on those concrete unanswered questions rather than broader generalizations about public-health impact.